EIC Fund completed the investment in SentryX.

EIC Fund, a venture investment arm of the European Innovation Council, completed the investment in SentryX, a clinical stage biopharmaceutical company developing non-opioid therapeutics for the treatment of acute pain after surgery. Financial terms were not disclosed.